Skip to content

Comparative investigation between the effectiveness of Achillea wilhelmsii tablet and group counseling based on acceptance and commitment on Pre Menstrual Syndrome (PMS) symptoms

Comparative investigation between the effectiveness of Achillea wilhelmsii tablet and group counseling based on acceptance and commitment on Pre Menstrual Syndrome (PMS) symptoms in students living in the dormitories

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201027049164N2
Enrollment
264
Registered
2021-09-16
Start date
2021-09-24
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual Syndrome. Premenstrual tension syndrome

Interventions

Intervention 1: Intervention group1: The counseling group will receive 8 sessions of 90-minute counseling based on acceptance and commitment once a week. Intervention 2: Intervention group2: The yarro

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: All samples should have a menstrual cycle duration of 35-24 days. Being single The age of the samples should be between 18-45 years. Samples with premenstrual syndrome for at least six months and tend to participate in the study. Do not have any mental or physical illness. Do not take any chemical and herbal medicines Do not take birth control pills Have at least one symptom of mental and physical symptoms that should begin 16 days after menstruation

Exclusion criteria

Exclusion criteria: Menstrual period is less than 3 days and more than 8 days Interval of menstrual cycles less than 24 days and more than 35 days Existence of severe stress in the last trimester such as: death of relatives, marriage or surgery Pregnant and lactating women Participating in a simultaneous counseling program

Design outcomes

Primary

MeasureTime frame
Symptoms of premenstrual syndrome. Timepoint: Beginning of the study (before the start of the intervention) and end of the intervention. Method of measurement: Daily Symptom Report Questionnaire (DSR).

Countries

Iran (Islamic Republic of)

Contacts

Public Contactzahra pakdel

Kerman University of Medical Sciences

zahrapakdel75@gmail.com+98 34 3132 5856

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026